Ventripoint Diagnostics Ltd. (TSXV:VPT)
Canada · Delayed Price · Currency is CAD 0.0900
-0.0050 (-5.26%)
Sep 2, 2026, 1:00 PM EST
Ventripoint Diagnostics Market Cap
Ventripoint Diagnostics has a market cap or net worth of CAD 18.15 million as of September 2, 2026. Its market cap has decreased by -5.91% in one year.
Market Cap
18.15M
Enterprise Value
20.43M
Revenue
147.77K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
ChartMarket Cap Chart
Since September 21, 2007, Ventripoint Diagnostics's market cap has increased from 6.82M to 18.15M, an increase of 165.89%. That is a compound annual growth rate of 5.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 18.15M | -22.97% |
| Dec 31, 2025 | 23.56M | 45.40% |
| Dec 31, 2024 | 16.20M | -64.98% |
| Dec 29, 2023 | 46.26M | 9.26% |
| Dec 30, 2022 | 42.34M | -21.10% |
| Dec 31, 2021 | 53.67M | 567.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cannabix Technologies | 60.19M |
| Theralase Technologies | 54.70M |
| Perimeter Medical Imaging AI | 43.73M |
| Cheelcare | 31.07M |
| Conavi Medical | 22.08M |
| MedX Health | 16.40M |
| Frequency Exchange | 15.92M |
| VVT Med | 15.24M |